Ramont L - Search Results

1

Lumcorin: a leucine-rich repeat 9-derived peptide from human lumican inhibiting melanoma cell migration.

Zeltz C, Brézillon S, Perreau C, Ramont L, Maquart FX, Wegrowski Y. Zeltz C, et al. Among authors: ramont l. FEBS Lett. 2009 Sep 17;583(18):3027-32. doi: 10.1016/j.febslet.2009.08.012. Epub 2009 Aug 15. FEBS Lett. 2009. PMID: 19686741 Free article.

2

Implication of interleukin-4 in wound healing.

Salmon-Ehr V, Ramont L, Godeau G, Birembaut P, Guenounou M, Bernard P, Maquart FX. Salmon-Ehr V, et al. Among authors: ramont l. Lab Invest. 2000 Aug;80(8):1337-43. doi: 10.1038/labinvest.3780141. Lab Invest. 2000. PMID: 10950124 Free article.

3

[Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].

Ramont L, Ngoc PT, Pignon B, Maquart FX. Ramont L, et al. Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):565-70. Ann Biol Clin (Paris). 2002. PMID: 12368142 Free article. French.

4

[Biological effects of collagen I and IV peptides].

Pasco S, Ramont L, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. J Soc Biol. 2003;197(1):31-9. J Soc Biol. 2003. PMID: 12868264 Review. French.

5

Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.

Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC. Ramont L, et al. Exp Cell Res. 2003 Nov 15;291(1):1-10. doi: 10.1016/s0014-4827(03)00336-7. Exp Cell Res. 2003. PMID: 14597403

6

An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion.

Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. Maquart FX, et al. Among authors: ramont l. Crit Rev Oncol Hematol. 2004 Mar;49(3):199-202. doi: 10.1016/j.critrevonc.2003.06.007. Crit Rev Oncol Hematol. 2004. PMID: 15036260 Review.

7

Control of melanoma progression by various matrikines from basement membrane macromolecules.

Pasco S, Ramont L, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. Crit Rev Oncol Hematol. 2004 Mar;49(3):221-33. doi: 10.1016/j.critrevonc.2003.09.006. Crit Rev Oncol Hematol. 2004. PMID: 15036262 Review.

8

The small leucine-rich proteoglycan lumican inhibits melanoma progression.

Vuillermoz B, Khoruzhenko A, D'Onofrio MF, Ramont L, Venteo L, Perreau C, Antonicelli F, Maquart FX, Wegrowski Y. Vuillermoz B, et al. Among authors: ramont l. Exp Cell Res. 2004 Jun 10;296(2):294-306. doi: 10.1016/j.yexcr.2004.02.005. Exp Cell Res. 2004. PMID: 15149859

9

In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model.

Pasco S, Ramont L, Venteo L, Pluot M, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. Exp Cell Res. 2004 Dec 10;301(2):251-65. doi: 10.1016/j.yexcr.2004.07.036. Exp Cell Res. 2004. PMID: 15530861

10

Control of melanoma cell invasion by type IV collagen.

Pasco S, Brassart B, Ramont L, Maquart FX, Monboisse JC. Pasco S, et al. Among authors: ramont l. Cancer Detect Prev. 2005;29(3):260-6. doi: 10.1016/j.cdp.2004.09.003. Epub 2004 Nov 23. Cancer Detect Prev. 2005. PMID: 15936594 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters